Sally M. Marshall

5.0k total citations
93 papers, 3.3k citations indexed

About

Sally M. Marshall is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Sally M. Marshall has authored 93 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Endocrinology, Diabetes and Metabolism, 26 papers in Nephrology and 24 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Sally M. Marshall's work include Chronic Kidney Disease and Diabetes (22 papers), Diabetes Management and Research (21 papers) and Diabetes Treatment and Management (15 papers). Sally M. Marshall is often cited by papers focused on Chronic Kidney Disease and Diabetes (22 papers), Diabetes Management and Research (21 papers) and Diabetes Treatment and Management (15 papers). Sally M. Marshall collaborates with scholars based in United Kingdom, Denmark and Australia. Sally M. Marshall's co-authors include Allan Flyvbjerg, K. G. M. M. Alberti, Martin K. Rutter, Kathryn White, Janet M. McComb, Roy Taylor, Azfar Zaman, Julian H. Barth, Giancarlo Viberti and Nicolas J. Pillon and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Sally M. Marshall

92 papers receiving 3.2k citations

Peers

Countries citing papers authored by Sally M. Marshall

Since Specialization

Citations

This map shows the geographic impact of Sally M. Marshall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally M. Marshall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally M. Marshall more than expected).

Fields of papers citing papers by Sally M. Marshall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sally M. Marshall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally M. Marshall. The network helps show where Sally M. Marshall may publish in the future.

Co-authorship network of co-authors of Sally M. Marshall

This figure shows the co-authorship network connecting the top 25 collaborators of Sally M. Marshall. A scholar is included among the top collaborators of Sally M. Marshall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally M. Marshall. Sally M. Marshall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Metabolic consequences of obesity and type 2 diabetes: Balancing genes and environment for personalized care 2021 ·Cell ·Nicolas J. Pillon, Ruth J. F. Loos, Sally M. Marshall, Juleen R. Zierath	155
2	Biomarkers associated with early stages of kidney disease in adolescents with type 1 diabetes 2020 ·Pediatric Diabetes ·M. Loredana Marcovecchio, Marco Colombo, R. Neil Dalton, Paul McKeigue, Paul Benitez‐Aguirre, Fergus Cameron, Scott T. Chiesa, Jennifer Couper, Maria E. Craig, Denis Daneman, Elizabeth A. Davis, John Deanfield, Kim C. Donaghue, Timothy W. Jones, Farid H. Mahmud, Sally M. Marshall, Andrew Neil, Helen M. Colhoun, David B. Dunger, (unknown)	10
3	Differences in thrombus structure and kinetics in patients with type 2 diabetes mellitus after non ST elevation acute coronary syndrome 2014 ·Thrombosis Research ·Girish Viswanathan, Sally M. Marshall, (unknown), Juan J. Badimón, Azfar Zaman	11
4	Natural History and Clinical Characteristics of CKD in Type 1 and Type 2 Diabetes Mellitus 2014 ·Advances in Chronic Kidney Disease ·Sally M. Marshall	45
5	Thrombus and antiplatelet therapy in type 2 diabetes mellitus 2012 ·Thrombosis and Haemostasis ·Girish Viswanathan, Sally M. Marshall, Clyde B. Schechter, (unknown), (unknown), Azfar Zaman	11
6	Standardization of HbA1c: good or bad? 2010 ·Nature Reviews Endocrinology ·Sally M. Marshall	5
7	Differential effects of dialysis and ultrafiltrate from individuals with CKD, with or without diabetes, on platelet phosphatidylserine externalization 2007 ·American Journal of Physiology-Renal Physiology ·Yingjie Wang, Werner Beck, Reinhold Deppisch, Sally M. Marshall, Nicholas A. Hoenich, Michael G. Thompson	0
8	Prevention and early detection of vascular complications of diabetes 2006 ·BMJ ·Sally M. Marshall, Allan Flyvbjerg	162
9	The effect of intrauterine environment and low glomerular number on the histological changes in diabetic glomerulosclerosis 2005 ·Diabetologia ·Susan Jones, Kathryn White, Allan Flyvbjerg, Sally M. Marshall	11
10	Is normalisation of serum potassium and magnesium always necessary in Gitelman Syndrome for a successful obstetric outcome? 2004 ·BJOG An International Journal of Obstetrics & Gynaecology ·Ansu Basu, (unknown), Roy Taylor, James M. Davison, Sally M. Marshall	33
11	Introduction of IFCC reference method for calibration of HbA_1c: implications for clinical care 2004 ·Diabetic Medicine ·Susan E. Manley, W. Garry John, Sally M. Marshall	17
12	Microalbuminuria is more frequent in South Asian than in European origin populations: a comparative study in Newcastle, UK 2003 ·Diabetic Medicine ·Colin Fischbacher, Raj Bhopal, Martin K. Rutter, Nigel Unwin, Sally M. Marshall, Martin White, K. G. M. M. Alberti	74
13	Significance of silent ischemia andmicroalbuminuria in predicting coronaryevents in asymptomatic patients with type 2 diabetes 2002 ·Journal of the American College of Cardiology ·Martin K. Rutter, (unknown), Janet M. McComb, Sally M. Marshall	83
14	Silent myocardial ischemia and microalbuminuria in asymptomatic subjects with non–insulin-dependent diabetes mellitus 1999 ·The American Journal of Cardiology ·Martin K. Rutter, Janet M. McComb, (unknown), Sally M. Marshall	56
15	Are diaries worthwhile in the diabetes clinic? A pilot study 1995 ·Practical Diabetes International ·(unknown), D. Kyne‐Grzebalski, Sally M. Marshall, Roy Taylor	1
16	Albumin excretion and vascular deaths in NIDDM 1995 ·Diabetologia ·(unknown), Janet Lutale, Sally M. Marshall	98
17	Effects of growth hormone and thyroxine on kidney insulin-like growth factor-I and renal growth in hypophysectomized rats 1993 ·Journal of Endocrinology ·Sally M. Marshall, Allan Flyvbjerg, (unknown), J. Weeke, Hans Ørskov	7
18	Circadian variation of blood pressure in patients with diabetic nephropathy 1992 ·Diabetologia ·Klavs Würgler Hansen, Margrethe Mau Pedersen, Sally M. Marshall, Jens Sandahl Christiansen, Carl Erik Mogensen	74
19	Screening for Microalbuminuria: Which Measurement? 1991 ·Diabetic Medicine ·Sally M. Marshall	98
20	URINARY EXCRETION OF HUMAN EPIDERMAL GROWTH FACTOR IN THE VARIOUS STAGES OF DIABETIC NEPHROPATHY 1989 ·Clinical Endocrinology ·Samuel Dagogo‐Jack, Sally M. Marshall, P. Kendall‐Taylor, K. G. M. M. Alberti	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact